Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Requiring Color Changes to Duragesic Pain Patches to Aid Safety

The US Food and Drug Administration (FDA) is requiring color changes to the writing on Duragesic (fentanyl) pain patches so they can be seen more easily.

REFINE

medications
- - (-) Remove Duragesic filter Duragesic
conditions
- - (-) Remove Patient Safety Education filter Patient Safety Education
  - Neuromuscular Disease (1) Apply Neuromuscular Disease filter
    Chronic Pain Conditions (1) Apply Chronic Pain Conditions filter